WINNIPEG, June 11 /CNW/ - (TSX:IM) - IMRIS announced today the
appointment of Derek Reimer CA as Executive Vice President, Finance and
Administration and Chief Financial Officer. Derek will replace Ron Sabourin
who will assume the role of Executive Vice President, Business Development
effective June 25, 2008.
Derek joins IMRIS after nearly seven years as Chief Financial Officer of
Medicure, a publicly traded biopharmaceutical company. Prior to that, he spent
8 years with Deloitte & Touche LLP where he provided support to international
companies in the financial services and insurance sectors. His experience
includes public reporting, CSA and SEC compliance, treasury, capital market
strategies and international investor relations.
"We are delighted that Derek has joined us to bring his skills and
experience in managing all aspects of IMRIS's financial operations," said
David Graves, Chairman, President and Chief Executive Officer. "With Derek on
board, Ron Sabourin will be able to devote much more of his time, energy and
talent to managing and executing our growth strategy in global markets."
IMRIS is a global leader in providing fully integrated, advanced surgical
imaging solutions designed to measurably improve patient outcomes. The
company's flagship product, IMRISneuro, utilizes patented technology that
allows a high field MRI scanner to move in to the operating room on demand,
providing imaging during the surgical procedure without compromising patient
safety. This unique and innovative system has been validated by leading
neurosurgeons around the world for use in world-class neuroscience centers.
For further information:
For further information: Susan McLeod, Manager, Marketing
Communications, IMRIS Inc., Tel: (204) 480-7094, Email: firstname.lastname@example.org